Financhill
Back

Gritstone Bio 10K Form

Sell
36

GRTS
Gritstone Bio

Last Price:
0.62
Seasonality Move:
-6.54%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive GRTS News And Ratings

See the #1 stock for the next 7 days that we like better than GRTS

GRTS Financial Statistics

Sales & Book Value

Annual Sales: $1.33M
Cash Flow: $-26.84M
Price / Cash Flow: 0
Annual Sales: $0.19
Price / Book: 3.43

Profitability

EPS (TTM): -1.09000
Net Income (TTM): $-133.03M
Gross Margin: --
Return on Equity: -244.95%
Return on Assets: -76.69%

Gritstone Bio Earnings Forecast

Key Gritstone Bio Financial Ratios

  • The Research & Development expenses have been 9,555.37% of Revenue.
  • The Interest Expense is -2.91% of Operating Income.
  • The Net Earning history of GRTS is -10,404.96% of Total Revenues.
  • Per Share Earnings over the last 8 years have been positive in 4 years.

Gritstone Bio Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: GRTS
CUSIP: 39868T
Website: gritstonebio.com

Debt

Debt-to-Equity Ratio: 1.83
Current Ratio: 2.54
Quick Ratio: 2.34

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

GRTS Technical Analysis vs Fundamental Analysis

Sell
36
Gritstone Bio (GRTS) is a Sell

Is Gritstone Bio a Buy or a Sell?

  • Gritstone Bio stock is rated a Sell
    The current Gritstone Bio [GRTS] share price is $0.64. The Score for GRTS is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.